key: cord-0768899-19wh15qo authors: Huang, Chuan; Zhou, Shuai-Feng; Gao, Li-Dong; Li, Shi-Kang; Cheng, Yu; Zhou, Wen-Jun; Huang, Zeng-Hui; Ji, Xi-Ren; Fan, Li-Qing; Zhang, Fan; Chen, Zi-Wei; Zhan, Zhi-Fei; Hu, Shi-Xiong; Wang, Shi-Ping; Ma, Xue-Jun; Zhu, Wen-Bing title: Risks associated with cryopreserved semen in a human sperm bank during and after the COVID-19 pandemic date: 2020-12-03 journal: Reprod Biomed Online DOI: 10.1016/j.rbmo.2020.11.015 sha: bf0b07c4ae026187ac0f169fefc21fca0d58a2f8 doc_id: 768899 cord_uid: 19wh15qo RESEARCH QUESTION: : What are the risks associated with cryopreserved semen collected during and after the coronavirus disease 2019 (COVID-19) pandemic wave in Wuhan, China? DESIGN: : We conducted a retrospective cohort study involving young adult men who were qualified sperm donors at the Hunan Province Human Sperm Bank (China) during the pandemic wave (January 1, 2020, to January 30, 2020) and after the wave and return to work (April 7, 2020, to May 30, 2020). One hundred paired semen and blood specimens from 100 donors were included, 50 paired semen and blood samples collected during the pandemic from 50 donors, and 50 semen and blood samples from another 50 donors collected upon work resumption when COVID-19 infections in the population were very low. Considering the low viral load in both the specimens, we used one-step single-tube nested quantitative real-time PCR (OSN-qRT-PCR) for SARS-CoV-2 detection. Moreover, to control the unacceptable risk of false-negative results, a second round of screening was performed with pooled RNA from negative semen samples using crystal digital PCR (cd-PCR). Naso-oropharyngeal swabs were not evaluated during the pandemic peak, but were negative for the 50 donors who collected semen after the COVID-19 wave of infections. RESULTS: : For individual blood and semen samples, the target genes, namely nucleocapsid protein (N) and open reading frame (ORF-1ab) genes, tested negative in all of the 100 paired samples. Further, as per cd-PCR results, there were >20,000 droplets per well in the RNA for each combined sample and no positive droplets were present for either of the aforementioned target genes. A total of 100 paired semen and blood samples from these two groups tested negative for SARS-CoV-2. CONCLUSIONS: : Cryopreserved semen at the Hunan Province Human Sperm Bank during and after the coronavirus disease 2019 (COVID-19) pandemic wave was free of SARS-CoV-2, and was judged safe for external use in the future.Utmost precaution should be exercised by all human sperm banks, and the use of highly secure devices and segregated cryovessels is encouraged. blood specimens from 100 donors were included, 50 paired semen and blood samples collected during the pandemic from 50 donors, and 50 semen and blood samples from another 50 donors collected upon work resumption when COVID-19 infections in the population were very low. Considering the low viral load in both the specimens, we used one-step single-tube nested quantitative real-time PCR (OSN-qRT-PCR) for SARS-CoV-2 detection. Moreover, to control the unacceptable risk of false-negative results, a second round of screening was performed with pooled RNA from negative semen samples using crystal digital PCR (cd-PCR). Naso-oropharyngeal swabs were not evaluated during the pandemic peak, but were negative for the 50 donors who collected semen after the COVID-19 wave of infections. For individual blood and semen samples, the target genes, namely nucleocapsid protein (N) and open reading frame (ORF-1ab) genes, tested negative in all of the 100 paired samples. Further, as per cd-PCR results, there were >20,000 In Wuhan (Hubei Province, China), several patients with pneumonia were admitted in hospitals from December 2019 onwards (Munster, et al., 2020) . On February 11, 2020, The WHO (Sun, et al., 2020) officially named this condition as coronavirus disease 2019 . COVID-19 is the third known zoonotic coronavirus disease after the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and the causative agents belong to the β-coronavirus cluster . COVID-19, caused by SARS coronavirus 2 (SARS-CoV-2), may manifest either as an asymptomatic infection or as mild to severe pneumonia. Considering the high infectivity of COVID-19, several countries implemented suppression and mitigation strategies, including mandated social distancing, restrictions to non-urgent medical care, and closure of nonessential businesses, to control the community spread of the virus. Despite these efforts, controlling COVID-19 is a major challenge to date. As of July 2020, >12 million confirmed cases of SARS-CoV-2 infection have been reported globally. Thus far, 27 viruses have been detected in semen and spermatozoa (Salam and Horby, 2017) ; therefore, many researchers have attempted to determine whether SARS-CoV-2 could be present in the semen. Many published studies showed that SARS-CoV-2 could not be detected in the semen from patients with COVID-19 Pan, et al., 2020; Song, et al., 2020; Pavone, et al., 2020; Holtmann, et al., 2020; Kayaaslan, et al., 2020) . The available evidence indicate that the risk of significant virus shedding into the semen is low, we cannot assume that this risk is acceptable if semen samples were to be cryopreserved during the pandemic. If SARS-CoV-2 with extremely low viral load is present in semen samples and liquid nitrogen in cryostores, the risk of transmission is bound to be amplified across the world. Real-time quantitative PCR (qRT-PCR) may not be able to detect nucleic acids in clinical samples with a low viral load, such as the semen and blood. However, in our previous study , we developed a novel one-step single-tube nested quantitative real-time PCR (OSN-qRT-PCR) assay to detect SARS-CoV-2 in clinical samples, and this method showed 10-fold higher sensitivity and specificity than that of standard qRT-PCR. Thus, we herein used OSN-qRT-PCR to assay cryopreserved semen and blood samples collected during and after the COVID-19 pandemic at the Hunan Province Human Sperm Bank. Moreover, to control the unacceptable risk of false-negative results, after screening, we performed the highly sensitive crystal digital PCR (cd-PCR) using RNA collected from negative semen samples. Our aim was to determine the risk associated with cryopreserved semen during and after the pandemic. We conducted a retrospective cohort study of young adult men who were qualified sperm donors at the Hunan Province Human Sperm Bank from January 1, 2020, to May 30, 2020. All donors signed informed consent forms during their first visit to the sperm bank, allowing to the use of their semen samples or data for scientific research purposes. The Ethics Committee of the Hunan Provincial Center for Disease Control and Prevention approved this study (Hunan-CDC IRB2020005). The guidelines are as follows (Huang, et al., 2019) : (a) donors must be between 22 and 45 years of age; (b) donors must be in good health, based on the results of a physical examination and a psychological evaluation by a qualified doctor, and have no familial history of a genetic disease; (c) fresh semen should have a liquefaction time of <60 min, sperm concentration ≥60 × 10 6 mL −1 , progressive sperm motility ≥ 60%, and percentage of normal morphology >30%; (d) post-thaw semen should have a motility of ≥40%, ≥12 × 10 6 motile sperm per vial, and a frozen-thaw survival rate ≥60%; and (e) potential donors must undergo laboratory testing to exclude individuals at high risk for sexually transmitted infections and genetic diseases, including HIV-1 and HIV-2, hepatitis B and C, syphilis, gonorrhea, mycoplasma, chlamydia, cytomegalovirus, toxoplasma gondii, rubella virus, herpes simplex virus types 1 and 2, and undergo a karyotype analysis. If potential donors test negative for all the above tests and fulfill the Chinese Ministry of Health guidelines outlined above, the donation process is initiated and the semen samples are cryopreserved. The samples must be cryopreserved for a minimum 6-month quarantine period prior to rescreening for HIV. We included 100 paired semen and blood samples from 100 donors. 50 paired semen and blood samples collected during the pandemic from 50 donors, 50 semen and blood samples collected upon work resumption from another 50 donors. Semen specimens were collected by means of masturbation into a sterile container after 2-7 days of abstinence. All specimens were assessed according to WHO recommendations(WHO, 2010). After liquefaction within 1 h of ejaculation, the samples were analyzed for volume and sperm concentration, morphology, and motility, as per motility grades defined by WHO (PR, progressive sperm; NP, non-progressive sperm; and IM, immotile sperm). 1.5ml whole blood samples were collected from each donors in blood tubes with Ethylene Diamine Tetraacetic Acid (EDTA) and stored in 2ml cryopreservation tubes at −80°C until required. The collection, transportation, storage, and analysis of specimens were strictly performed according to the SARS-CoV-2 Laboratory Biosafety Guidelines (second edition) (Commission) nucleocapsid protein (N) gene) channels were selected to detect SARS-CoV-2, and the HEX channel was chosen to detect the reference gene(ribonuclease P, RNase P). Each run contained a positive control and negative control. The FAM, HEX, and ROX channels showed a typical S-shaped amplification curve, and when the Ct values of both target genes (ORF-1ab and N genes) was ≤ 39, the result was considered to be positive. After screening, RNA was co-extracted from all negative semen samples in groups of 10, these pooled RNA samples (n = 10 in total) were subjected to cd-PCR, which was performed on a Stilla Naica System TM for Crystal Digital TM PCR (France) was considered to be positive. The detection limit was 100 copies/mL. The mean semen volume for sperm donors was 2.5 (1.5-4. As per OSN-qRT-PCR results, the target ORF-1ab and N genes were not detected in any of the semen and blood samples (i.e., negative result, with Ct > 39). The reference gene was, however, detectable (mean Ct value of semen sample = 22.32 and of blood sample = 24.41; Table 1 ). The FAM, HEX, and ROX channels of the positive control showed a typical S-shaped amplification curve, and the Ct value was >39 for the negative control. After screening by OSN-qRT-PCR, the 100 negative semen samples were divided into groups of 10, from group 1 (1-10) to 10 (90-100). RNA was extracted from these 10 groups, pooled, and further analyzed using cd-PCR. The total number of droplets per well for all the combined samples was >20,000, indicating good test validity. The threshold line for the blue (FAM), green (VIC), and red (CY5) channel was 18,000, 18,000, and 17,500, respectively. As evident from Figure 1 , no positive droplets for the N (blue channel) and ORF-1ab (green channel) genes were detected in the 10 semen samples; all the (gray in Figure 1 ) droplets below the threshold line were negative. The human conserved region gene (IC) showed (red in Figure 1 ) positive droplets, with the mean number of positive droplets being 2899. The number of positive droplets for the N gene was 21 (Blue-Pos) and that for the ORF-1ab gene was 12 After screening with OSN-qRT-PCR and cd-PCR, all samples from qualified sperm donors during the pandemic wave ( January 1, 2020, to January 30, 2020) and after the wave and return to work ( April 7, 2020, to May 30, 2020), tested negative for SARS-CoV-2 ( Figure 2 ; red diamonds represent samples collected during the pandemic from 50 donors, whereas green diamonds represent samples collected upon work resumption from another 50 donors). A total of 100 paired semen (dark gray triangles) and blood (light gray triangles) samples from these two groups tested negative for SARS-CoV-2. Several countries are currently dealing with SARS-CoV-2. The rapid emergence of the COVID-19 pandemic has presented a serious challenge to healthcare systems across the globe. Accordingly, many countries have implemented suppression and mitigation strategies to control the spread of SARS-CoV-2; social and economic activities are, however, gradually being resumed. Hunan Province fully resumed work in April 2020, and the Hunan Human Sperm Bank resumed work on April 17, 2020. At present, the "lockdown" has been completely lifted in China. However, asymptomatic people are a threat as they can infect healthy individuals, consequently leading to another outbreak (Zou, et al., 2020) . During the pandemic, several reproduction centers canceled fertility treatments (La Marca, et al., 2020; Rodriguez-Wallberg and Wikander, 2020) . Although the association between SARS-CoV-2 and treatment involving artificial reproductive technologies remains uncertain, Some infertility centers have provided guidance, including the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine Ory, et al., 2020) . They recommended suspending the initiation of new treatments and an alternative freeze-all protocol in cases where couples have already undergone human chorionic gonadotropin triggering; further, cryopreservation of gametes was recommended for cases of urgent fertility preservation (Anifandis, et al., 2020) . It is noteworthy that most viruses remain viable at ultra-low temperatures if stored dried, in appropriate protein concentrations (Gould, 1999) . SARS-CoV-2 is an enveloped RNA virus, so evaluation of the presence of SARS-CoV-2 in seminal samples is particularly important for semen cryopreservation, because viruses stored in liquid nitrogen retain their pathogenic properties (De Paoli, 2005) .Angiotensin-converting enzyme 2 (ACE2) is highly tissue-specific, with significant levels being detected only in the heart, kidneys, testes, and gastrointestinal tract (Harmer, et al., 2002) . In the testes, ACE2 is expressed in spermatogenic cells ; a recent study reported that ACE2 is also expressed in human Leydig and Sertoli cells , implying a direct effect of the virus on the male reproductive system. Another study reported that SARS-CoV-2 infection can upregulate ACE2 expression. Considering that SARS-CoV-2 acts through the ACE2 receptor (Li, et al., 2003) , a possible direct effect of SARS-CoV-2 on spermatozoa cannot be excluded. Only one paper has reported detection of the virus in semen of patients with COVID-19 , but the paper lacks information on details on patient characteristics and does not report on the method used to detect the virus in semen, it cannot be excluded that virus from other sources other than the male reproductive tract . A major challenge is the possibility of transmission by asymptomatic individuals. Not only is it crucial to detect SARS-CoV-2 in asymptomatic men who are going to freeze semen as donors, but also for cancer patients and in patients who are going to cryopreserve sperm for use in ICSI (Jose, et al., 2020) .As yet, no studies have directly detected the presence of SARS-CoV-2 in the semen obtained from sperm donors. These donors could be asymptomatic individuals or at the early stage of an infection; therefore, highly sensitive methods are needed to detect SARS-CoV-2, rather than simply using standard qRT-PCR. qRT-PCR is the gold standard method that is widely used in many diagnostic laboratories in China for the etiological detection of SARS-CoV-2 (Udugama, et al., 2020) . However, depending on the sample type, sample quality, RNA extraction method, and RNA quality, the viral load may be lower than the detection limit of qRT-PCR, leading to false-negative results. The sensitivity of OSN-qRT-PCR is reportedly 1 copy/reaction, which is 10-fold higher than that of qRT-PCR performed using a commercial kit . In addition, OSN-qRT-PCR is cost effective and easy to perform, making it ideal for samples with a low viral load. However, in case of semen and blood samples, their viral load is far less than that of stool samples, sputum samples, and throat and nasal swabs; despite the fact that all blood and semen samples tested negative by OSN-qRT-PCR in this study, OSN-qRT-PCR remains a robust method to screen a large quantity of samples with a low viral load. Herein we performed a second round of screening using cd-PCR. Which is also suitable for screening samples with a low viral load (Li, et al., 2018) . This method involves using a single chip to partition samples into 2D droplet arrays, which are then subjected to thermal cycling and finally read using a three-color fluorescence scanning device. This technology allows three-color multiplexing, which entails a different approach to data analysis, making the results more reliable (Madic, et al., 2016) . As the use of cd-PCR involves specific reagents and instruments and professional operators, it is expensive with moderate throughput, and is thus unsuitable for screening a large number of samples. In this study, we performed cd-PCR using a mixture of negative semen samples that were by first screened with OSN-qRT-PCR; this substantially lowered the cost. The cd-PCR results confirmed our OSN-qRT-PCR results, markedly increasing the robustness of our the data reported in this study. This study has a few limitations. First, although we did not detect SARS-CoV-2 in cryopreserved semen and blood samples, we cannot exclude the possibility that the virus could be detected in samples collected in the acute phase. Second, we only tested 100 paired semen and blood specimens from 100 donors; further studies that involve a larger cohort are thus warranted. Finally, our study population represents only one geographical region of China, and the results may therefore not be applicable to China as a whole. To conclude, to the best of our knowledge, this is the first study to use highly sensitive assays to determine the presence of SARS-CoV-2 in cryopreserved semen during and after the COVID-19 pandemic. Our findings clearly illustrate that cryopreserved semen at the Hunan Province Human Sperm Bank during and after the coronavirus disease 2019 (COVID-19) pandemic was free of SARS-CoV-2. Nevertheless, we advise that utmost precaution be exercised by all human sperm banks at such a time, and the use of highly secure devices and segregated cryovessels is encouraged. All authors disclose no conflicts of interest. and light gray triangles: negative results for blood samples. COVID-19 and fertility: a virtual reality Emerging coronaviruses: Genome structure, replication, and pathogenesis Office of Department of Science Technical Guide for Laboratory Detection of pneumonia infected by novel coronavirus (fourth Edition)/pneumonia Prevention and Control Program for novel coronavirus infection Bio-banking in microbiology: from sample collection to epidemiology, diagnosis and research Methods for long-term virus preservation Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme Assessment of SARS-CoV-2 in human semen-a cohort study SARS-CoV-2 infection: implications for sexual and reproductive health Investigation of SARS-CoV-2 in Semen of Patients in the Acute Stage of COVID-19 Infection COVID-19: lessons from the Italian reproductive medical experience Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease Application of droplet digital PCR to detect the pathogens of infectious diseases Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes A Novel Coronavirus Emerging in China -Key Questions for Impact Assessment The global impact of COVID-19 on infertility services No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019 SARS-CoV-2 presence in seminal fluid: Myth or reality Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab Italian males recovering from mild COVID-19 show no evidence of SARS-CoV-2 in semen despite prolonged nasopharyngeal swab positivity A global recommendation for restrictive provision of fertility treatments during the COVID-19 pandemic The Breadth of Viruses in Human Semen Absence of 2019 novel coronavirus in semen and testes of COVID-19 patientsdagger Understanding of COVID-19 based on current evidence Diagnosing COVID-19: The Disease and Tools for Detection Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS Assisted reproduction and COVID-19: A joint statement of ASRM, ESHRE and IFFS Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2 scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Human conserved region gene (gray: negative droplet, red: positive droplet) Chuan Huang obtained PhD degree in genetics in 2017 at the Central South University, China. Since 2017 she has been a member of the human sperm bank at Reproductive and Genetic Hospital of CITIC-Xiangya. Her current research interests is male fertility preservation We are thankful to the Chinese Center for Disease Control and Prevention and the National Institute for Viral Disease Control and Prevention.key message This retrospective cohort study found that cryopreserved semen at the Hunan Province Human Sperm Bank during and after the coronavirus disease 2019 (COVID-19) pandemic was free of SARS-CoV-2, which is safety to external use in the future.